Total submissions: 18
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000121680 | SCV000228070 | benign | not specified | 2015-04-06 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000229594 | SCV000290271 | benign | Adams-Oliver syndrome 5 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000121680 | SCV000520857 | benign | not specified | 2016-10-05 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV002313937 | SCV000738276 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2015-02-23 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001699039 | SCV002546128 | benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | NOTCH1: BS1, BS2 |
Genome- |
RCV000229594 | SCV002554463 | benign | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002269856 | SCV002554464 | benign | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002492434 | SCV002796000 | likely benign | Aortic valve disease 1; Adams-Oliver syndrome 5 | 2021-10-08 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000121680 | SCV003928449 | likely benign | not specified | 2023-04-09 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001699039 | SCV004562951 | benign | not provided | 2023-11-13 | criteria provided, single submitter | clinical testing | |
ITMI | RCV000121680 | SCV000085878 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
University of Washington Center for Mendelian Genomics, |
RCV001291515 | SCV001480023 | uncertain significance | Hypoplastic left heart syndrome | no assertion criteria provided | research | ||
Diagnostic Laboratory, |
RCV000121680 | SCV001739563 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000121680 | SCV001797828 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000121680 | SCV001808719 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001699039 | SCV001927041 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001699039 | SCV001953685 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000121680 | SCV001971509 | benign | not specified | no assertion criteria provided | clinical testing |